269. 化膿性無菌性関節炎・壊疽性膿皮症・アクネ症候群 Pyogenic arthritis Clinical trials / Disease details
臨床試験数 : 23 / 薬物数 : 30 - (DrugBank : 12) / 標的遺伝子数 : 15 - 標的パスウェイ数 : 106
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04901325 (ClinicalTrials.gov) | September 29, 2021 | 17/5/2021 | Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG) | Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG) | Pyoderma Gangrenosum;Skin Diseases;Wound Heal;Pyoderma;Skin Ulcer | Drug: Baricitinib | Oregon Health and Science University | NULL | Suspended | 18 Years | 99 Years | All | 20 | Phase 2 | United States |